Ubs Group Ag Immunocore Holdings PLC Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Ubs Group Ag holds 22,552 shares of IMCR stock, worth $718,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,552

Previous 176,132 87.2%

Holding current value

$718,732

Previous $5.23 Million 86.47%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$24.53 - $38.65 $3.77 Million - $5.94 Million	-153,580 Reduced 87.2%	22,552 $707,000
Q1 2025 May 13, 2025	BUY	$28.21 - $33.0 $999,367 - $1.17 Million	35,426 Added 25.18%	176,132 $5.23 Million
Q4 2024 Feb 14, 2025	BUY	$28.14 - $34.69 $2.73 Million - $3.36 Million	96,987 Added 221.84%	140,706 $4.15 Million
Q3 2024 Nov 14, 2024	BUY	$30.06 - $41.49 $917,431 - $1.27 Million	30,520 Added 231.23%	43,719 $1.36 Million
Q2 2024 Aug 13, 2024	SELL	$33.78 - $63.75 $2,736 - $5,163	-81 Reduced 0.61%	13,199 $447,000
Q1 2024 May 13, 2024	BUY	$60.14 - $75.36 $719,935 - $902,134	11,971 Added 914.51%	13,280 $863,000
Q4 2023 Feb 09, 2024	SELL	$42.85 - $69.5 $7,241 - $11,745	-169 Reduced 11.43%	1,309 $89,000
Q3 2023 Nov 09, 2023	SELL	$49.5 - $66.6 $19,701 - $26,506	-398 Reduced 21.22%	1,478 $76,000
Q2 2023 Aug 11, 2023	BUY	$48.54 - $61.64 $10,727 - $13,622	221 Added 13.35%	1,876 $112,000
Q1 2023 May 12, 2023	SELL	$46.12 - $65.71 $225,711 - $321,584	-4,894 Reduced 74.73%	1,655 $81,000
Q4 2022 Feb 08, 2023	BUY	$45.51 - $65.08 $28,534 - $40,805	627 Added 10.59%	6,549 $373,000
Q3 2022 Nov 10, 2022	SELL	$37.34 - $57.44 $43,837 - $67,434	-1,174 Reduced 16.54%	5,922 $278,000
Q2 2022 Aug 10, 2022	SELL	$25.46 - $37.72 $33,403 - $49,488	-1,312 Reduced 15.6%	7,096 $265,000
Q1 2022 May 16, 2022	SELL	$18.94 - $34.29 $19,640 - $35,558	-1,037 Reduced 10.98%	8,408 $251,000
Q4 2021 Feb 14, 2022	SELL	$27.58 - $40.0 $125,654 - $182,240	-4,556 Reduced 32.54%	9,445 $323,000
Q3 2021 Nov 15, 2021	BUY	$27.98 - $40.0 $55,596 - $79,480	1,987 Added 16.54%	14,001 $519,000
Q2 2021 Aug 13, 2021	BUY	$32.22 - $41.5 $10,987 - $14,151	341 Added 2.92%	12,014 $469,000
Q1 2021 May 12, 2021	BUY	$36.3 - $56.34 $423,729 - $657,656	11,673 New	11,673 $497,000

Others Institutions Holding IMCR

# of Institutions

146

Shares Held

45.1M

Call Options Held

297K

Put Options Held

1.17M

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.4B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account